The Protective Effect of Mitochondrial ATP-Sensitive K+ Channel Opener, Nicorandil, Combined With Na+/Ca2+ Exchange Blocker KB-R7943 on Myocardial Ischemia-Reperfusion Injury in Rat

Cell Biochemistry and Biophysics

Volumn 60, Issue 3, 2011, Pages 219-224

  Jia, Dalin ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Cardiac function; KB R7943; Myocardial infarction; Nicorandil

Indexed keywords

2 (2 (4 (4 NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; 2-(2-(4-(4-NITROBENZYLOXY)PHENYL)ETHYL)ISOTHIOUREA METHANESULFONATE; ANTIARRHYTHMIC AGENT; DRUG DERIVATIVE; MALONALDEHYDE; MITOCHONDRIAL K(ATP) CHANNEL; NICORANDIL; POTASSIUM CHANNEL; SODIUM CALCIUM EXCHANGE PROTEIN; SUPEROXIDE DISMUTASE; THIOUREA;

ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; FEMALE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MALE; METABOLISM; RAT; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; FEMALE; MALE; MALONDIALDEHYDE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NICORANDIL; POTASSIUM CHANNELS; RATS; RATS, WISTAR; SODIUM-CALCIUM EXCHANGER; SUPEROXIDE DISMUTASE; THIOUREA;

RATTUS; RATTUS NORVEGICUS;

EID: 79958256136     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-010-9142-8     Document Type: Article

References (31)

1. + channel openers. Pharmacology and Therapeutics, 85, 39-53.
2. Gross, G. J., & Auchampach, J. A. (1992). Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circulation Research, 70(2), 223.
3. Rajesh, K. G., Sasaguri, S., Suzuki, R., et al. (2004). Ischemic preconditioning prevents reperfusion heart injury in cardiac hypertrophy by activation of mitochondrial KATP channels. International Journal of Cardiology, 96(1), 41.
4. + channel as a receptor for potassium channel openers. Journal of Biological Chemistry, 271, 8796-8799.
5. Nakai, Y., Horimoto, H., & Mieno, S. (2001). Mitochondrial ATP-sensitive potassium channel plays a dominant role in ischemic preconditioning of rabbit heart. European Surgical Research, 33, 57-63.
6. 2+ exchange molecule: An overview. Annals of the New York Academy of Sciences, 976, 1-10.
7. + regulation in cardiac myocytes. Cardiovascular Research, 57, 897-912.
8. 2+ exchange current in guinea-pig ventricular myocytes. Journal of Physiology, 529, 611-623.
9. 2+ exchange inhibitors in attenuating ischemia-reperfusion injury. Canadian Journal of Cardiology, 21, 509-516.
10. 2+ exchanger using novel drugs and genetically engineered mice. Folia Pharmacologica Japonica (Nippon Yakurigaku Zasshi), 120(1), 91P-93P.
11. 2+ exchanger. Molecular Pharmacology, 59, 524-531.
12. 2+ exchange by KB-R7943: Transport mode selectivity and antiarrhythmic consequences. American Journal of Physiology, 281, H1334-H1345.
13. 2+ exchanger. American Journal of Physiology, 276, 1868-1876.
14. 2+ exchanger in reoxygenation-induced cardiomyocyte injury. Cardiovascular Research, 51, 241-250.
15. 2+ exchanger at the time of myocardial reperfusion on hypercontracture and cell death. Cardiovascular Research, 55, 739-748.
16. 2+ exchanger inhibitors SEA0400 and KB-R7943. American Journal of Physiology, 284, H903-H910.
17. + exchanger for protection of the myocardium from lethal reperfusion injury. Cardiovascular Drugs and Therapy, 16, 295-301.
18. Tsuchida, A., Miura, T., Tanno, M., et al. (2002). Infarct size limitation by nicorandil: Roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. Journal of the American College of Cardiology, 40(8), 1523-1530.
19. Jia, D., Zheng, X.-W., Qi, G. X., et al. (2000). The influence of KATP channel opener JTV-506 on areas of isolated myocardial infarction in rat. Acta Pharmaceutica Sinica, 35(10), 743-746.
20. Taira, N. (1987). Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: An overview. Journal of Cardiovascular Pharmacology, 10, S1-S9.
21. Taira, N. (1989). Nicorandil as a hybrid between nitrates and potassium channel activators. American Journal of Cardiology, 63, 18J-24J.
22. Krumenacker, M., & Roland, E. (1992). Clinical profile of a nicorandil: An overview of its hemodynamic properties and therapeutic efficacy. Journal of Cardiovascular Pharmacology, 20, S93-S102.
23. Imagawa, J., Baxter, G. F., & Yellon, D. M. (1998). Myocardial Protection afforded by nicorandil and ischemic preconditioning in a rabbit infarct model invivo. Journal of Cardiovascular Pharmacology, 31, 74-79.
24. Mizumura, T., Nithipatikom, K., & Gross, G. J. (1995). Effects of nicorandil and glyceryl trinitrate on infarct size, adenosine release, and neutrophil infiltration in the dog. Cardiovascular Research, 29, 482-489.
25. Patel, D. J., Purcell, H. J., & Fox, K. M. (1999). Cardioprotection by opening of the KATP channel in unstable angina: Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European Studies in Angina and Revascularization. European Heart Journal, 20, 51-57.
26. Maxwell, S. R., & Lip, G. Y. (1997). Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. International Journal of Cardiology, 58, 95-117.
27. Gross, G. J., Pieper, G., Farber, N. E., et al. (1989). Effects of nicorandil on coronary circulation and myocardial ischemia. American Journal of Cardiology, 63, 11J-17J.
28. Lazdunski, M., Frelin, C., & Vigne, P. (1985). The sodium/hydrogen exchange system in cardiac cells; its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. Journal of Molecular and Cellular Cardiology, 17, 1029-1042.
29. Griffiths, E., & Halestrap, A. P. (1993). Protection by cyclosporine A of ischemia/reperfusion-induced damage in isolated rat hearts. Journal of Molecular and Cellular Cardiology, 25, 1461-1469.
30. 2+ inhibitor, on myocardial ischemia/reperfusion injury. Folia Pharmacologica Japonica (Nippon Yakurigaku Zasshi), 111, 105-115. (Abstr. in English).
31. Elmali, N., Esenkaya, I., & Karadag, N. (2007). Effects of resveratrol on skeletal muscle in ischemic-reperfusion injury. Ulusal Travma ve Acil Cerrahi Dergisi, 13, 274-280.